{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:10:36Z","timestamp":1793725836413,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Otorrinolaringologica (English Edition)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.otoeng.2026.512328","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T23:39:47Z","timestamp":1771717187000},"page":"512328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating mepolizumab and dupilumab for severe chronic rhinosinusitis with nasal polyps: insights from a real-life study"],"prefix":"10.1016","volume":"77","author":[{"given":"Laura","family":"G\u00e1lvez-Gafo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Mari\u00f1o-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Yeguas-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Mu\u00f1oz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez-Cu\u00e9llar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar\u00edo","family":"Antol\u00edn-Am\u00e9rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonz\u00e1lez-De-Olano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Santamar\u00eda-Gadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl S29","key":"10.1016\/j.otoeng.2026.512328_bib0005","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinol J"},{"issue":"5","key":"10.1016\/j.otoeng.2026.512328_bib0010","first-page":"384","article-title":"Prevalence of chronic rhinosinusitis with nasal polyps in catalonia (Spain): a retrospective, large-scale population-based study","volume":"60","author":"Sanchez-Collado","year":"2022","journal-title":"Rhinology."},{"issue":"4","key":"10.1016\/j.otoeng.2026.512328_bib0015","first-page":"421","article-title":"Prevalence of chronic rhinosinusitis without\/with nasal polyps according to severity in Spain","volume":"62","author":"Mullol","year":"2024","journal-title":"Rhinology."},{"issue":"5","key":"10.1016\/j.otoeng.2026.512328_bib0020","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato","year":"2022","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"10.1016\/j.otoeng.2026.512328_bib0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18176\/jiaci.0910","article-title":"Spanish consensus on the management of chronic rhinosinusitis with nasal polyps (POLIposis NAsal\/POLINA 2.0)","volume":"33","author":"Alobid","year":"2023","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"11","key":"10.1016\/j.otoeng.2026.512328_bib0030","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1007\/s00405-024-08790-y","article-title":"The use of biologics in patients suffering from chronic rhinosinusitis with nasal polyps - a 4-year real life observation","volume":"281","author":"Frankenberger","year":"2024","journal-title":"Eur Arch Otorhinolaryngol."},{"issue":"10","key":"10.1016\/j.otoeng.2026.512328_bib0035","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/all.15772","article-title":"Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational Phase IV real-life study (DUPIREAL)","volume":"78","author":"De Corso","year":"2023","journal-title":"Allergy."},{"issue":"10","key":"10.1016\/j.otoeng.2026.512328_bib0040","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med."},{"issue":"5","key":"10.1016\/j.otoeng.2026.512328_bib0045","first-page":"343","article-title":"The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology."},{"issue":"11","key":"10.1016\/j.otoeng.2026.512328_bib0050","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.jaip.2021.06.037","article-title":"Prevalence and symptom burden of nasal polyps in a large Austrian population","volume":"9","author":"Campion","year":"2021","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"3","key":"10.1016\/j.otoeng.2026.512328_bib0055","first-page":"194","article-title":"EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"issue":"6","key":"10.1016\/j.otoeng.2026.512328_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.18176\/jiaci.0939","article-title":"Improvement in smell using monoclonal antibodies among patients with chronic rhinosinusitis with nasal polyps: a systematic review","volume":"33","author":"Barroso","year":"2023","journal-title":"J Investig Allergol Clin Immunol."},{"issue":"9","key":"10.1016\/j.otoeng.2026.512328_bib0065","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1007\/s00405-024-08553-9","article-title":"Efficacy of dupilumab in real-life settings: a STROBE study","volume":"281","author":"Gal","year":"2024","journal-title":"Eur Arch Otorhinolaryngol."},{"issue":"12","key":"10.1016\/j.otoeng.2026.512328_bib0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13123575","article-title":"Real-life evidence of mepolizumab treatment in chronic rhinosinusitis with nasal polyps: a multicentric study","volume":"13","author":"Cavaliere","year":"2024","journal-title":"J Clin Med."},{"issue":"5","key":"10.1016\/j.otoeng.2026.512328_bib0075","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item sinonasal outcome test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"issue":"2","key":"10.1016\/j.otoeng.2026.512328_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.otohns.2003.09.016","article-title":"Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale","volume":"130","author":"Stewart","year":"2004","journal-title":"Otolaryngol Head Neck Surg."},{"issue":"4","key":"10.1016\/j.otoeng.2026.512328_bib0085","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/all.15650","article-title":"European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis","volume":"78","author":"Gevaert","year":"2023","journal-title":"Allergy."},{"issue":"10","key":"10.1016\/j.otoeng.2026.512328_bib0090","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/lary.24654","article-title":"Modification of the Lund-Kennedy endoscopic scoring system improves its reliability and correlation with patient-reported outcome measures","volume":"124","author":"Psaltis","year":"2014","journal-title":"Laryngoscope."},{"issue":"4","key":"10.1016\/j.otoeng.2026.512328_bib0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.18176\/jiaci.0824","article-title":"The 8-Odorant Barcelona Olfactory Test (BOT-8): validation of a new test in the Spanish population during the COVID-19 pandemic","volume":"32","author":"Rojas-Lechuga","year":"2022","journal-title":"J Investig Allergol Clin Immunol."},{"key":"10.1016\/j.otoeng.2026.512328_bib0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy."},{"key":"10.1016\/j.otoeng.2026.512328_bib0105","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12081304","article-title":"Mepolizumab improves outcomes of chronic rhinosinusitis with nasal polyps in severe asthmatic patients: a multicentric real-life study","volume":"12","author":"Gallo","year":"2022","journal-title":"J Pers Med."},{"issue":"2","key":"10.1016\/j.otoeng.2026.512328_bib0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biomedicines11020485","article-title":"Real-life effectiveness of mepolizumab in refractory chronic rhinosinusitis with nasal polyps","volume":"11","author":"Dom\u00ednguez-Sosa","year":"2023","journal-title":"Biomedicines."},{"issue":"3","key":"10.1016\/j.otoeng.2026.512328_bib0115","first-page":"320","article-title":"Mepolizumab improves sense of smell in severe chronic rhinosinusitis with nasal polyps: SYNAPSE","volume":"62","author":"Mullol","year":"2024","journal-title":"Rhinology."}],"container-title":["Acta Otorrinolaringologica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573526000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573526000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:53:38Z","timestamp":1791446018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173573526000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2173573526000086"],"URL":"https:\/\/doi.org\/10.1016\/j.otoeng.2026.512328","relation":{},"ISSN":["2173-5735"],"issn-type":[{"value":"2173-5735","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating mepolizumab and dupilumab for severe chronic rhinosinusitis with nasal polyps: insights from a real-life study","name":"articletitle","label":"Article Title"},{"value":"Acta Otorrinolaringologica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otoeng.2026.512328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Otorrinolaringolog\u00eda y Cirug\u00eda de Cabeza y Cuello. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"512328"}}